Metabolon, Inc., a world leader in metabolomics-based diagnostic tests and research services, announced today that it has raised $15 million in a Series E financing through the issuance of preferred stock. New investor Camden Partners led ...
Tags: Metabolon, Series E financing, Camden Partners, financing
Metabolon has signed a multi-year research alliance with Japan based Takeda to develop new therapeutic targets and biomarkers. Under the collaboration, Metabolon will apply its platform to discover and validate targets, and identify ...
Tags: Drug Discovery Alliance, Takeda's R&D programs, metabolomic profiling